These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 18843846

  • 1. [Expression of bcl-2, Ki-67 and p-53 in uveal melanomas].
    Krvavica A, Talan-Hranilović J, Belicza M.
    Acta Med Croatica; 2008 Jul; 62(3):267-71. PubMed ID: 18843846
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Ki-67, p53 and bcl-2 analysis in colonic versus rectal adenocarcinoma.
    Petrişor O, Giuşcă SE, Sajin M, Dobrescu G, Căruntu ID.
    Rom J Morphol Embryol; 2008 Jul; 49(2):163-71. PubMed ID: 18516322
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Immunohistochemical expression of bcl-2 in Dukes' stage B and C colorectal carcinoma patients: correlation with p53 and ki-67 in evaluating prognostic significance.
    Zavrides H, Zizi-Sermpetzoglou A, Elemenoglou I, Papatheofanis I, Peros G, Athanasas G, Panousopoulos D.
    Pol J Pathol; 2005 Jul; 56(4):179-85. PubMed ID: 16477877
    [Abstract] [Full Text] [Related]

  • 6. Immunohistochemical and prognostic analysis of apoptosis and proliferation in uveal melanoma.
    Mooy CM, Luyten GP, de Jong PT, Luider TM, Stijnen T, van de Ham F, van Vroonhoven CC, Bosman FT.
    Am J Pathol; 1995 Oct; 147(4):1097-104. PubMed ID: 7573354
    [Abstract] [Full Text] [Related]

  • 7. Correlation between proliferation markers: PCNA, Ki-67, MCM-2 and antiapoptotic protein Bcl-2 in colorectal cancer.
    Guzińska-Ustymowicz K, Pryczynicz A, Kemona A, Czyzewska J.
    Anticancer Res; 2009 Aug; 29(8):3049-52. PubMed ID: 19661314
    [Abstract] [Full Text] [Related]

  • 8. Prediction of aggressiveness of gastrointestinal stromal tumours based on immunostaining with bcl-2, Ki-67 and p53.
    Meara RS, Cangiarella J, Simsir A, Horton D, Eltoum I, Chhieng DC.
    Cytopathology; 2007 Oct; 18(5):283-9. PubMed ID: 17883690
    [Abstract] [Full Text] [Related]

  • 9. Ki-67 and p53 expression in minimal deviation melanomas as compared with other nevomelanocytic lesions.
    Chorny JA, Barr RJ, Kyshtoobayeva A, Jakowatz J, Reed RJ.
    Mod Pathol; 2003 Jun; 16(6):525-9. PubMed ID: 12808056
    [Abstract] [Full Text] [Related]

  • 10. Prognostic value of immunohistochemistry in gastric neuroendocrine (carcinoid) tumors.
    Safatle-Ribeiro AV, Ribeiro U, Corbett CE, Iriya K, Kobata CH, Sakai P, Yagi OK, Pinto PE, Zilberstein B, Gama-Rodrigues J.
    Eur J Gastroenterol Hepatol; 2007 Jan; 19(1):21-8. PubMed ID: 17206073
    [Abstract] [Full Text] [Related]

  • 11. Expression of p53-induced apoptosis effector PERP in primary uveal melanomas: downregulation is associated with aggressive type.
    Paraoan L, Gray D, Hiscott P, Ebrahimi B, Damato B, Grierson I.
    Exp Eye Res; 2006 Oct; 83(4):911-9. PubMed ID: 16784742
    [Abstract] [Full Text] [Related]

  • 12. Cyclin A expression in superficial spreading malignant melanomas correlates with clinical outcome.
    Flørenes VA, Maelandsmo GM, Faye R, Nesland JM, Holm R.
    J Pathol; 2001 Dec; 195(5):530-6. PubMed ID: 11745687
    [Abstract] [Full Text] [Related]

  • 13. Human leukocyte antigen class I expression. Marker of poor prognosis in uveal melanoma.
    Blom DJ, Luyten GP, Mooy C, Kerkvliet S, Zwinderman AH, Jager MJ.
    Invest Ophthalmol Vis Sci; 1997 Aug; 38(9):1865-72. PubMed ID: 9286277
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of putative molecular biomarkers in abdominal and retroperitoneal leiomyosarcomas.
    Shpitz B, Tiomkin V, Bomstein Y, Gralkin M, Buklan H, Bernheim J, Klein E.
    Eur J Surg Oncol; 2001 Mar; 27(2):203-8. PubMed ID: 11289760
    [Abstract] [Full Text] [Related]

  • 15. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
    Ioachim E.
    Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Possible implications of MCAM expression in metastasis and non-metastatic of primary uveal melanoma patients.
    Beutel J, Wegner J, Wegner R, Ziemssen F, Nassar K, Rohrbach JM, Hilgers RD, Lüke M, Grisanti S.
    Curr Eye Res; 2009 Nov; 34(11):1004-9. PubMed ID: 19958117
    [Abstract] [Full Text] [Related]

  • 20. Primary melanoma of the skin and cutaneous melanomatous metastases: comparative histologic features and immunophenotypes.
    Guerriere-Kovach PM, Hunt EL, Patterson JW, Glembocki DJ, English JC, Wick MR.
    Am J Clin Pathol; 2004 Jul; 122(1):70-7. PubMed ID: 15272532
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.